BLUE BELL, Pa., March 18, 2013 — /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) today reported financial results for the fourth quarter and year ended December 31, 2012.
Total revenue was $1.1 million and $4.1 million for the quarter and year ended December 31, 2012, compared to $1.6 million and $9.8 million for the same periods in 2011.
Total revenue was $1.1 million and $4.1 million for the quarter and year ended December 31, 2012, compared to $1.6 million and $9.8 million for the same periods in 2011.
